secwatch.observer — SEC 8-K summary
======================================

Issuer:     TENAX THERAPEUTICS, INC. (TENX)
CIK:        0000034956
Form:       8-K
Filed at:   2024-01-19T23:59:59+00:00
Accession:  0001654954-24-000770
Event type: other_material
Sentiment:  positive
Materiality: 0.75
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Tenax Therapeutics regains compliance with Nasdaq minimum bid price rule
------------------------------------------------------------------------

- Received Nasdaq written confirmation on Jan 18, 2024, after 10 consecutive trading days (Jan 3-17) closing at $1.00 or greater.
- Originally notified of bid price deficiency on March 29, 2023; later granted extension through March 25, 2024.
- Compliance achieved ahead of extension deadline; delisting risk removed.
- Bid Price Rule (Nasdaq Listing Rule 5550(a)(2)) matter now closed.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/34956/000165495424000770/0001654954-24-000770-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/34956/000165495424000770/tenx_8k.htm
  HTML page:      https://secwatch.observer/filing/0001654954-24-000770

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer